Research map: HDL particle concentration, but not HDL cholesterol, is inversely associated with mortality after liver transplantation

Back to the article

Papers in this map

  1. Estimating Glomerular Filtration Rate from Serum Creatinine and Cystatin C · Lesley A. Inker · 2012 · 4136 citations · Cited by this paper
  2. Long-term treatment of homozygous familial hypercholesterolemia with lomitapide: 11 years of safety and effectiveness findings from the Lomitapide Observational Worldwide Evaluation Registry (LOWER) · 2026 · Related
  3. Thematic review series: The Pathogenesis of Atherosclerosis. Effects of infection and inflammation on lipid and lipoprotein metabolism mechanisms and consequences to the host · Weerapan Khovidhunkit · 2004 · 1494 citations · Cited by this paper
  4. Healthcare Resource Utilization Among Patients Receiving Olezarsen Versus Placebo for Severe Hypertriglyceridemia in CORE/CORE2 Clinical Trials · 2026 · Related
  5. HDL Cholesterol Efflux Capacity and Incident Cardiovascular Events · Anand K. Rohatgi · 2014 · 1417 citations · Cited by this paper
  6. Population-Based Screening for Familial Hypercholesterolemia (FH) — Insights from a Large Integrated Healthcare System · 2026 · Related
  7. Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures. · Brian J. Van Lenten · 1995 · 846 citations · Cited by this paper
  8. Target LDL-C vs. ApoB in a Patient with Familial Hypercholesterolemia · 2026 · Related
  9. Dysfunctional HDL and atherosclerotic cardiovascular disease · Robert S. Rosenson · 2015 · 835 citations · Cited by this paper
  10. Charting New Territories in the Management of Individuals with Immune-Mediated Inflammatory Disease and Obesity: Calming Concomitant Pathologies · 2026 · Related
  11. Evolution of Causes and Risk Factors for Mortality Post‐Liver Transplant: Results of the NIDDK Long‐Term Follow‐Up Study · K.D.S. Watt · 2010 · 792 citations · Cited by this paper
  12. Apolipoprotein B-low-density lipoprotein cholesterol discordance refines cardiovascular risk stratification across metabolic phenotypes · 2026 · Related
  13. GlycA: A Composite Nuclear Magnetic Resonance Biomarker of Systemic Inflammation · James Dorian Otvos · 2015 · 417 citations · Cited by this paper
  14. Lipid Medical Optimization in Coronary Artery Disease in Patients Presented at Multidisciplinary "Heart Team" · 2026 · Related
  15. High-density lipoprotein revisited: biological functions and clinical relevance · Arnold von Eckardstein · 2022 · 397 citations · Cited by this paper
  16. Radiographic measurement of the Achilles tendon for diagnosis of familial hypercholesterolemia · 2026 · Related
  17. Small, Dense High-Density Lipoprotein-3 Particles Are Enriched in Negatively Charged Phospholipids · Laurent Camont · 2013 · 323 citations · Cited by this paper
  18. Real-World Distribution and Clinical Correlates of Coronary Artery Calcium in Hispanic Individuals · 2026 · Related
  19. High-Density Lipoprotein Cholesterol, Size, Particle Number, and Residual Vascular Risk After Potent Statin Therapy · Samia Mora · 2013 · 241 citations · Cited by this paper
  20. Predicting Genetically Defined Familial Hypercholesterolaemia with the FAMCAT Algorithm in an Australian Tertiary Clinic · 2026 · Related
  21. Triglyceride enrichment of HDL enhances in vivo metabolic clearance of HDL apo A-I in healthy men · Benoı̂t Lamarche · 1999 · 232 citations · Cited by this paper
  22. Cholesterol Efflux Capacity, High-Density Lipoprotein Particle Number, and Incident Cardiovascular Events · Amit V. Khera · 2017 · 227 citations · Cited by this paper
  23. Myeloperoxidase: An Oxidative Pathway for Generating Dysfunctional High-Density Lipoprotein · Baohai Shao · 2009 · 184 citations · Cited by this paper
  24. OPTN/SRTR 2023 Annual Data Report: Liver · Allison J. Kwong · 2025 · 172 citations · Cited by this paper
  25. High density lipoproteins and endothelial functions: mechanistic insights and alterations in cardiovascular disease · Meliana Riwanto · 2013 · 171 citations · Cited by this paper
  26. Serum amyloid A impairs the antiinflammatory properties of HDL · Chang Yeop Han · 2015 · 171 citations · Cited by this paper
  27. NMR measurement of LDL particle number using the Vantera® Clinical Analyzer · Steven P. Matyus · 2014 · 170 citations · Cited by this paper
  28. Rationale and design of TransplantLines: a prospective cohort study and biobank of solid organ transplant recipients · Michele Freerk Eisenga · 2018 · 143 citations · Cited by this paper
  29. Remodeling of HDL by CETP in vivo and by CETP and hepatic lipase in vitro results in enhanced uptake of HDL CE by cells expressing scavenger receptor B-I · Xavier Collet · 1999 · 132 citations · Cited by this paper
  30. Role of HDL Cholesterol and Estimates of HDL Particle Composition in Future Development of Type 2 Diabetes in the General Population: The PREVEND Study · Ali Abbasi · 2013 · 130 citations · Cited by this paper
  31. Post-transplant dyslipidemia: Mechanisms, diagnosis and management · Arnav Agarwal · 2016 · 120 citations · Cited by this paper
  32. Associations Between High-Density Lipoprotein Particles and Ischemic Events by Vascular Domain, Sex, and Ethnicity · Kavisha Singh · 2020 · 86 citations · Cited by this paper
  33. Calorie restriction improves lipid-related emerging cardiometabolic risk factors in healthy adults without obesity: Distinct influences of BMI and sex from CALERIE™ a multicentre, phase 2, randomised controlled trial · Kim M. Huffman · 2022 · 85 citations · Cited by this paper
  34. Inflammation reduces HDL protection against primary cardiac risk · James P. Corsetti · 2010 · 69 citations · Cited by this paper
  35. HDL Particle Subspecies and Their Association With Incident Type 2 Diabetes: The PREVEND Study · Sara Sokooti · 2021 · 66 citations · Cited by this paper
  36. Myeloperoxidase, inflammation, and dysfunctional high-density lipoprotein · Jonathan D. Smith · 2010 · 62 citations · Cited by this paper
  37. Medical management of metabolic and cardiovascular complications after liver transplantation · Chiara Becchetti · 2020 · 53 citations · Cited by this paper
  38. Decreased paraoxonase-1 activity is associated with alterations of high-density lipoprotein particles in chronic liver impairment · Judit Marsillach · 2010 · 51 citations · Cited by this paper
  39. High-Density Lipoprotein Modifications: A Pathological Consequence or Cause of Disease Progression? · Andrea Bonnin Márquez · 2020 · 51 citations · Cited by this paper

Source: OpenAlex (CC0)